FDA issues PML warning for MS patients taking Gilenya
FDA issues PML warning for MS patients taking Gilenya
Following reports of progressive multifocal leukoencephalopathy among patients taking Gilenya for multiple sclerosis, the FDA has issued a warning of possible infection for those prescribed the immunosuppressant drug.... Read More - http://www.ms-uk.org/gilenya
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 5 Replies
- 12969 Views
-
Last post by gibbledygook
-
- 4 Replies
- 2338 Views
-
Last post by JohnC777
-
- 0 Replies
- 1403 Views
-
Last post by frodo
-
- 0 Replies
- 1432 Views
-
Last post by NHE
-
- 0 Replies
- 2207 Views
-
Last post by frodo